TMO - Principia Sanofi Rumors And Other News: The Good Bad And Ugly Of Biopharma
Principia Biopharma Perks Up on Sanofi Rumors
Principia Biopharma (PRNB) shot up due to swirling rumors regarding Sanofi's (SNY) interest in the firm. The French pharma company is currently looking to expand its presence in the United States and is weighing different options. Principia is a late-stage biopharmaceutical firm and is mainly invested in developing novel therapies of immune-mediated diseases.
Sanofi is on a restructuring spree under the leadership of its new CEO, who took on the charge last year. Earlier this year, the company reported that it plans to slash its workforce by up